{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:47:42Z","timestamp":1793598462147,"version":"4.5.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013428","name":"Stichting Spieren voor Spieren","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013428","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167087","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T20:07:30Z","timestamp":1480363650000},"page":"e0167087","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls"],"prefix":"10.1371","volume":"11","author":[{"given":"Renske I.","family":"Wadman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"van der Weegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel A.","family":"Wijngaarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Harschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sodaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees P. J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Dooijes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henny H.","family":"Lemmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ludo","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"S Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"CL Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.gde.2013.03.003","article-title":"How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches","volume":"23","author":"B Wirth","year":"2013","journal-title":"Curr Opin Genet Dev"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1523\/JNEUROSCI.3631-10.2011","article-title":"The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons","volume":"31","author":"C Fallini","year":"2011","journal-title":"J Neurosci"},{"issue":"7584","key":"ref5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature16469","article-title":"SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination","volume":"529","author":"DY Zhao","year":"2016","journal-title":"Nature"},{"issue":"5599","key":"ref6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1126\/science.1074962","article-title":"Essential role for the SMN complex in the specificity of snRNP assembly","volume":"298","author":"L Pellizzoni","year":"2002","journal-title":"Science"},{"issue":"25","key":"ref7","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1073\/pnas.1104928108","article-title":"Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits","volume":"108","author":"B Akten","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons","volume":"163","author":"W Rossoll","year":"2003","journal-title":"J Cell Biol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI71318","article-title":"Dysregulation of ubiquitin homeostasis and beta-catenin signaling promote spinal muscular atrophy","volume":"124","author":"TM Wishart","year":"2014","journal-title":"J Clin Invest"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"AH Burghes","year":"2009","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","article-title":"SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy","volume":"5","author":"KJ Swoboda","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ejhg.2012.233","article-title":"Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study","volume":"21","author":"FD Tiziano","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","article-title":"SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy","volume":"6","author":"JT Kissel","year":"2011","journal-title":"PLoS One"},{"issue":"24","key":"ref14","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1212\/WNL.0b013e3182020332","article-title":"Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy","volume":"75","author":"TH Chen","year":"2010","journal-title":"Neurology"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmg.2010.080366","article-title":"Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design","volume":"47","author":"FD Tiziano","year":"2010","journal-title":"J Med Genet"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","article-title":"Phase II open label study of valproic acid in spinal muscular atrophy","volume":"4","author":"KJ Swoboda","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"CJ Sumner","year":"2003","journal-title":"Ann Neurol"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.2009.200253","article-title":"Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid","volume":"82","author":"S Piepers","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mus.23904","article-title":"SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy","volume":"49","author":"JT Kissel","year":"2014","journal-title":"Muscle Nerve"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.ejhg.5200286","article-title":"SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis","volume":"7","author":"AL Patrizi","year":"1999","journal-title":"Eur J Hum Genet"},{"issue":"25","key":"ref21","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1523\/JNEUROSCI.0204-12.2012","article-title":"Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy","volume":"32","author":"TL Martinez","year":"2012","journal-title":"J Neurosci"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"e33572","DOI":"10.1371\/journal.pone.0033572","article-title":"Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study","volume":"7","author":"TO Crawford","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/hmg\/dds437","article-title":"VPA response in SMA is suppressed by the fatty acid translocase CD36","volume":"22","author":"L Garbes","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"DD Coovert","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","article-title":"In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate","volume":"59","author":"L Brichta","year":"2006","journal-title":"Ann Neurol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ejhg.2011.89","article-title":"Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability","volume":"19","author":"E Also-Rallo","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbrc.2014.09.087","article-title":"A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry","volume":"453","author":"M Arakawa","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pediatrneurol.2016.05.009","article-title":"Imaging Flow Cytometry Analysis to Identify Differences of Survival Motor Neuron Protein Expression in Patients With Spinal Muscular Atrophy","volume":"61","author":"R Arakawa","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","article-title":"SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials","volume":"66","author":"CJ Sumner","year":"2006","journal-title":"Neurology"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1177\/0883073807305666","article-title":"Molecular functions of the SMN complex","volume":"22","author":"SJ Kolb","year":"2007","journal-title":"J Child Neurol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ejhg.2009.116","article-title":"SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR","volume":"18","author":"FD Tiziano","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"e0139950","DOI":"10.1371\/journal.pone.0139950","article-title":"Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls","volume":"10","author":"C Czech","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"e24269","DOI":"10.1371\/journal.pone.0024269","article-title":"Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analyses","volume":"6","author":"DT Kobayashi","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"e50763","DOI":"10.1371\/journal.pone.0050763","article-title":"Evaluation of peripheral blood mononuclear cell processing and analysis for Survival Motor Neuron protein","volume":"7","author":"DT Kobayashi","year":"2012","journal-title":"PLoS One"},{"issue":"22","key":"ref35","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/01.wnl.0000313038.34337.b1","article-title":"A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy","volume":"71","author":"M Nguyen thi","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"e0150640","DOI":"10.1371\/journal.pone.0150640","article-title":"SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials","volume":"11","author":"P Zaworski","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/adt.2015.635","article-title":"Detection of survival motor neuron protein in buccal cells through electrochemiluminescence-based assay","volume":"13","author":"H Steinkellner","year":"2015","journal-title":"Assay Drug Dev Technol"},{"issue":"17","key":"ref38","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"JG Chang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"ref39","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1093\/hmg\/ddu142","article-title":"Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy","volume":"23","author":"JG Boyer","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","author":"M Bowerman","year":"2012","journal-title":"Ann Neurol"},{"issue":"14","key":"ref41","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1093\/hmg\/ddv148","article-title":"Astrocytes influence the severity of spinal muscular atrophy","volume":"24","author":"H Rindt","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/hmg\/ddt612","article-title":"SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy","volume":"23","author":"G Hunter","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/7.12.1927","article-title":"The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy","volume":"7","author":"P Burlet","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"CA Chiriboga","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","author":"G Hamilton","year":"2013","journal-title":"Trends Mol Med"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"K Zerres","year":"1995","journal-title":"Arch Neurol"},{"issue":"5\u20136","key":"ref47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany)","volume":"2","author":"TL Munsat","year":"1992","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","article-title":"Childhood spinal muscular atrophy: controversies and challenges","volume":"11","author":"E Mercuri","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1090-3798(99)80012-9","article-title":"Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype","volume":"3","author":"V Dubowitz","year":"1999","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-0004.2009.01200.x","article-title":"Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling","volume":"76","author":"S Rudnik-Schoneborn","year":"2009","journal-title":"Clin Genet"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.21832","article-title":"Insights into genotype-phenotype correlations in spinal muscular atrophy: a retrospective study of 103 patients","volume":"43","author":"F Petit","year":"2011","journal-title":"Muscle Nerve"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0960-8966(91)90051-S","article-title":"Chaos in classification of the spinal muscular atrophies of childhood","volume":"1","author":"V Dubowitz","year":"1991","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.nmd.2008.05.008","article-title":"Survival in SMA type I: a prospective analysis of 34 consecutive cases","volume":"18","author":"JM Cobben","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"ref54","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/0883073811420294","article-title":"Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III","volume":"26","author":"AM Glanzman","year":"2011","journal-title":"J Child Neurol"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients","volume":"13","author":"C Brahe","year":"2005","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","article-title":"Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA","volume":"68","author":"LR Simard","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"C Andreassi","year":"2004","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-510X(99)00325-1","article-title":"Analysis of the mRNA transcripts of the survival motor neuron (SMN) gene in the tissue of an SMA fetus and the peripheral blood mononuclear cells of normals, carriers and SMA patients","volume":"173","author":"YJ Jong","year":"2000","journal-title":"J Neurol Sci"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/sj.ejhg.5201885","article-title":"A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy","volume":"15","author":"M Vezain","year":"2007","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/jme.0.0250169","article-title":"Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays","volume":"25","author":"SA Bustin","year":"2000","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition","volume":"18","author":"J Hauke","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/bio.2010.0009","article-title":"Gene Expression Profiles from Peripheral Blood Mononuclear Cells Are Sensitive to Short Processing Delays","volume":"8","author":"MG Barnes","year":"2010","journal-title":"Biopreserv Biobank"},{"issue":"11","key":"ref64","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1017\/S0007114510002710","article-title":"Time-dependent changes in the expression of lymphocyte and monocyte cell adhesion molecules after meals of different composition","volume":"104","author":"E Torrecilla","year":"2010","journal-title":"Br J Nutr"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.nmd.2014.05.013","article-title":"The influence of storage parameters on measurement of survival motor neuron (SMN) protein levels: implications for pre-clinical studies and clinical trials for spinal muscular atrophy","volume":"24","author":"G Hunter","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CDLI.6.1.14-19.1999","article-title":"Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study","volume":"6","author":"CA Kleeberger","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2249.2010.04272.x","article-title":"Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society","volume":"163","author":"R Mallone","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"23","key":"ref68","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1093\/hmg\/ddi390","article-title":"The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation","volume":"14","author":"F Gabanella","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"ref69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.jnen.0000205144.54457.a3","article-title":"Neuronal-specific roles of the survival motor neuron protein: evidence from survival motor neuron expression patterns in the developing human central nervous system","volume":"65","author":"A Giavazzi","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"ref70","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000324623.89105.c4","article-title":"Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude","volume":"71","author":"F Deymeer","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"ref71","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00415-008-0929-0","article-title":"A natural history study of late onset spinal muscular atrophy types 3b and 4","volume":"255","author":"S Piepers","year":"2008","journal-title":"J Neurol"},{"issue":"5","key":"ref72","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/CDLI.5.5.632-635.1998","article-title":"Age-related changes in blood lymphocyte subsets of Saudi Arabian healthy children","volume":"5","author":"S Shahabuddin","year":"1998","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T15:18:25Z","timestamp":1601219905000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167087"}},"subtitle":[],"editor":[{"given":"Thomas H","family":"Gillingwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":72,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167087","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}